Marker Therapeutics is a Texas-based biotechnology firm that develops and commercializes novel T-cell therapies for the treatment of blood cancers and solid tumors diseases.
Business Model:
Revenue: $6.9M
Employees: 51-200
Address: 4551 Kennedy Commerce Drive
City: Houston
State: TX
Zip: 77032
Country: US
Marker Therapeutics is a Texas-based biotechnology firm that develops and commercializes novel T-cell therapies for the treatment of blood cancers and solid tumors diseases.
Contact Phone:
+17134006400
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/5/1998
Ticker Symbol:
MRKR
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2021 | Post-IPO Equity | $56.5M | 9/2022 | Grant | $2M |
U.S. Food and Drug Administration |
9/2022 | Grant | $2M | 5/2018 | Equity | $3.1M | 6/2017 | Equity | $6.2M | 12/2022 | Post-IPO Equity | 1 | $25M |
Lincoln Park Capital Fund Lincoln Park Capital Fund |
8/2021 | Grant | 1 | $13.1M |
Cancer Prevention and Research Institute of Texas Cancer Prevention and Research Institute of Texas |
---|
Announced Date | Name | Price |
---|---|---|
5/2018 | TapImmune |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|